Search for stock quotes, financial statistics and more
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target on ... Read More
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target pri... Read More
Research Capital analyst Andre Uddin maintained a “Speculative buy” rating and C$0.70 target pri... Read More
Following the company’s second quarter results, Research Capital analyst Andre Uddin is mainta... Read More
New interim clinical data has Research Capital Corporation analyst André Uddin feeling more bullish... Read More